{
    "SPADE_N_14579": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14579",
            "Peptide Name": "P2 (LL-37(5-24) analog, Arg-rich, synthetic AMPs, XXA, UCLL1c)",
            "Source": "sequence truncation, amino acid SUBSTITUTION, human cathelicidin analog, animal-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FFRRSRERIGREFRRIVQRI",
            "Sequence Length": 20,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2678.11,
            "PI": 12.0,
            "Hydrophobicity": -1.08,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Krishnamoorthy R, Adhikari P, Anaikutti P. 2023",
                    "Reference": "RSC Adv. 2023 May 23;13(23):15594-15605. doi: 10.1039/d3ra02473c.PubMed",
                    "Title": "Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37."
                }
            ],
            "Frequent Amino Acids": "RFI",
            "Absent Amino Acids": "ACDHKLMNOPTUWY",
            "Basic Residues": 8,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 7,
            "Polar Residues": 11,
            "Positive Residues": 8,
            "Negative Residues": 2,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (68%) toLL-25R: 40%, F: 15%.Activity: active against S. aureus (MIC 22 ug/ml), B. subtilis (MIC 25 ug/ml), E. coli (MIC 20 ug/ml), and P. aeruginosa (MIC 25 ug/ml).Structure: random coil in buffer and helical in TFE or SDS.In vitro toxicity: not hemo.lytic till 100 uM.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_04575",
                    "Similarity": 1.0,
                    "Sequence": "GIINTLQKYYFRVRGGRFAVLSFLPKEEQIGKFSTRGRKFFRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_04581",
                    "Similarity": 1.0,
                    "Sequence": "RGRKFFRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_04590",
                    "Similarity": 1.0,
                    "Sequence": "RGRKFFRR"
                }
            ]
        }
    }
}